🔎 Trials Near Me

Gara Jalqabaatti › COPD › Indiana

Qorannoo klinikaalii COPD Indiana keessatti

Qorannoo 10 COPD f Indiana keessatti hirmaatuu jiru.

Magaalota Indiana keessatti

Takkalaa qorannoo (Ingiliffa)

Acoustic Waveform Respiratory Evaluation

  • Indiana University, Indianapolis
Namoota walitti qabaa jiraHojjettoota fayyaa simatamoo
Umuriin 8 hanga 70 · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT06512064

A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease

  • Research Site, Valparaiso
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 40 hanga 80 · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT06283966

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype

  • Asha Clinical Research - Munster- Site Number : 8400115, Hammond
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 40 hanga 80 · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT07190222

To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment

  • DM Clinical Research-Indianapolis, Indianapolis
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 40 hanga 85 · Saalaa hunda · Haaromfame 30-Ful-2026 · NCT07684820

A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)

  • Indiana University Health University Hospital, Indianapolis
  • IU Health Ball Memorial Hospital, Inc., Muncie
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 40 hanga 75 · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT07759245

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype

  • Indy Clinical Research- Site Number : 8400071, Indianapolis
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 40 hanga 80 · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT07190209

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)

  • Research Site, Munster
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 40 hanga 80 · Saalaa hunda · Haaromfame 03-Ful-2026 · NCT06883305

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)

  • Research Site, Evansville
  • Research Site, Indianapolis
  • Research Site, Indianapolis
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 40 hanga 80 · Saalaa hunda · Haaromfame 03-Ful-2026 · NCT06878261

The Study of Chronic Obstructive Pulmonary Disease (COPD) Participants Treated With Dupilumab (STRIDE) Registry

  • IU Health Pulmonology & Critical Care Medicine, Indianapolis
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 40 fi ol · Saalaa hunda · Haaromfame 01-Ful-2026 · NCT07612878

A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease

  • ASHA Clinical Research - Munster, LLC, Hammond
  • Methodist Hospital Southlake, Merrillville
Namoota walitti qabaa jiraSadarkaa 2/3
Umuriin 35 hanga 80 · Saalaa hunda · Haaromfame 31-Hag-2026 · NCT07363694

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.